Bladder Cancer,Genitourinary Cancer EV+P Improves Survival in LA/mUC: Compliance Impact Evaluated May 31, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab + Lazertinib vs Osimertinib in High-Risk EGFR NSCLC May 31, 2024
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Ivonescimab + Chemo Improves PFS in Patients With EGFR-TKI Failure May 31, 2024
Gastrointestinal Cancer,Liver Cancer Efficacy and Safety of Immunotherapy + FOLFOX for HCC May 30, 2024